Security Snapshot

SELLAS Life Sciences Group, Inc. - COMMON STOCK (SLS) Institutional Ownership

CUSIP: 81642T209

13F Institutional Holders and Ownership History from Q4 2019 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

116

Shares (Excl. Options)

38.09MFull value: 38,086,975 · shares · 30 Sep 2026

Price

$12.31

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-3,789,367
Value change
-$58,927,368
Number of holders
116
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
203,393,608
SEC-reported price per share
$12.41
Insider filing price
$12.41
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • SLS - SELLAS Life Sciences Group, Inc. - COMMON STOCK is tracked under CUSIP 81642T209.
  • 116 institutions reported positions in Q3 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 192 to 116 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $1.08BFull value: $1,079,069,829 · USD · 30 Jun 2026
    to
    $468.15MFull value: $468,152,857 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 116 institutions filings for Q3 2026.

Open SEC evidence

Security key

81642T209

13F reference period

Q3 2026

13F holders

116

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
SLS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.9% +16% $195,392,752 +$45,994,518 15,872,685 +31% BlackRock, Inc. 30 Sep 2026
STATE STREET CORP 5.1% -27% $128,729,848 -$32,557,436 10,373,074 -20% STATE STREET CORPORATION 30 Sep 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $121,988,428 9,666,278 Vanguard Capital Management 30 Jun 2026
Anson Funds Management LP 4.9% -13% $31,046,889 +$6,010,196 7,481,178 +24% Anson Funds Management LP 31 Dec 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 3.7% $24,560,261 6,514,658 Highbridge Capital Management, LLC 31 Dec 2025
As of 30 Sep 2026, 116 institutional investors reported holding
38.09MFull value: 38,086,975 · shares · 30 Sep 2026
shares of SELLAS Life Sciences Group, Inc. - COMMON STOCK (SLS). This represents 19% of the company’s total
203.39MFull value: 203,393,608 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
18%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
STATE STREET CORP 5.1% 10,373,074 -20% 0% $127,692,541
VANGUARD CAPITAL MANAGEMENT LLC 4.4% 8,942,647 +8.7% 0% $110,083,985
GEODE CAPITAL MANAGEMENT, LLC 2.5% 5,171,819 +5.9% 0% $63,677,118
VANGUARD PORTFOLIO MANAGEMENT LLC 1.1% 2,297,581 +6.3% 0% $28,283,222
MORGAN STANLEY 0.74% 1,511,107 +22% 0% $18,601,728
VANGUARD FIDUCIARY TRUST CO 0.71% 1,441,271 +7.9% 0% $17,742,046
DAGCO, INC. 0.66% 1,336,449 +8.4% 2.9% $16,451,691
GROUP ONE TRADING LLC 0.34% 684,301 0.26% $8,423,745
Swiss National Bank 0.2% 397,600 +10% 0% $4,894,456
Creative Planning 0.18% 368,727 +422% 0% $4,539,030
MARSHALL WACE, LLP 0.14% 283,834 0% $3,493,997
LPL Financial LLC 0.14% 277,075 +78% 0% $3,410,793
ALPS ADVISORS INC 0.13% 267,545 +42% 0.02% $3,293,479
Rafferty Asset Management, LLC 0.12% 245,946 +2.5% 0.01% $3,027,595
Everhart Financial Group, Inc. 0.12% 240,213 -17% 0.18% $2,957,022
Mariner, LLC 0.11% 226,857 +14% 0% $2,792,602
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0.11% 226,799 +12% 0% $2,791,896
POLEN CAPITAL MANAGEMENT LLC 0.11% 218,091 0.03% $2,684,700
RAYMOND JAMES FINANCIAL INC 0.1% 205,145 0% $2,525,333
DEUTSCHE BANK AG\ 0.1% 197,537 +3.9% 0% $2,431,680
FRANKLIN TEMPLETON INC 0.1% 195,673 +64% 0% $1,788,452
Harvest Investment Services, LLC 0.09% 184,585 +95% 0.39% $2,272,241
Vontobel Holding Ltd. 0.07% 147,719 +0.65% 0.01% $1,818,421
VANGUARD ASSET MANAGEMENT, Ltd 0.07% 145,811 +16% 0% $1,794,933
Tidal Investments LLC 0.07% 133,032 +3.3% 0% $1,637,624

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
28
Headline period
Q3 2026
Rows shown
1-25 of 28
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 38,086,975 $468,152,857 -$58,927,368 $12.31 116
2026 Q2 73,491,015 $1,079,069,829 +$308,980,802 $14.76 192
2026 Q1 53,961,117 $228,425,549 +$70,779,572 $4.23 160
2025 Q4 35,512,660 $133,935,339 +$23,683,756 $3.77 112
2025 Q3 32,917,301 $53,012,951 +$9,796,863 $1.61 92
2025 Q2 26,771,579 $58,629,839 +$27,498,028 $2.19 78
2025 Q1 14,287,843 $15,431,614 +$8,743,246 $1.08 43
2024 Q4 6,195,241 $6,443,955 +$751,049 $1.04 29
2024 Q3 5,385,570 $6,729,539 +$1,661,405 $1.25 30
2024 Q2 4,056,846 $4,828,846 -$3,466,325 $1.19 29
2024 Q1 7,717,105 $7,794,727 +$4,207,509 $1.01 27
2023 Q4 3,493,044 $3,702,505 +$352,826 $1.06 29
2023 Q3 2,751,676 $4,512,830 -$594,241 $1.64 25
2023 Q2 3,114,137 $4,889,035 +$175,383 $1.57 22
2023 Q1 2,996,127 $4,284,993 +$1,438,716 $1.43 20
2022 Q4 1,889,269 $4,456,259 +$91,291 $2.36 27
2022 Q3 2,186,943 $4,418,000 -$1,738,313 $2.02 25
2022 Q2 2,979,307 $6,641,000 +$1,671,317 $2.23 23
2022 Q1 1,688,629 $11,276,000 -$279,247 $6.68 25
2021 Q4 1,733,782 $9,586,000 -$1,340,161 $5.53 26
2021 Q3 1,859,470 $17,100,000 -$844,204 $9.16 29
2021 Q2 1,897,926 $21,282,000 +$4,739,163 $11.10 28
2021 Q1 1,552,743 $13,246,990 +$5,287,808 $8.54 28
2020 Q4 925,075 $5,374,000 +$2,503,596 $5.81 17
2020 Q3 616,674 $1,633,000 +$397,179 $2.65 10
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .